AQR Capital Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,590
| Closed | -$463K | – | 2327 |
|
|
2022
Q3 | $463K | Sell |
30,590
-50,423
| -62% | -$763K | ﹤0.01% | 1817 |
|
|
2022
Q2 | $608K | Buy |
81,013
+41,813
| +107% | +$314K | ﹤0.01% | 1614 |
|
|
2022
Q1 | $357K | Buy |
39,200
+14,520
| +59% | +$132K | ﹤0.01% | 1924 |
|
|
2021
Q4 | $173K | Buy |
+24,680
| New | +$173K | ﹤0.01% | 2106 |
|
|
2018
Q3 | – | Sell |
-4,176
| Closed | -$282K | – | 2351 |
|
|
2018
Q2 | $282K | Sell |
4,176
-7,141
| -63% | -$482K | ﹤0.01% | 2139 |
|
|
2018
Q1 | $614K | Sell |
11,317
-10,074
| -47% | -$547K | ﹤0.01% | 1843 |
|
|
2017
Q4 | $1.28M | Sell |
21,391
-13,687
| -39% | -$818K | ﹤0.01% | 1573 |
|
|
2017
Q3 | $1.71M | Buy |
35,078
+457
| +1% | +$22.2K | ﹤0.01% | 1440 |
|
|
2017
Q2 | $1.82M | Buy |
34,621
+3,715
| +12% | +$195K | ﹤0.01% | 1423 |
|
|
2017
Q1 | $1.4M | Buy |
30,906
+5,206
| +20% | +$236K | ﹤0.01% | 1541 |
|
|
2016
Q4 | $973K | Buy |
+25,700
| New | +$973K | ﹤0.01% | 1705 |
|
|
2015
Q3 | – | Sell |
-49,878
| Closed | -$880K | – | 2287 |
|
|
2015
Q2 | $880K | Buy |
49,878
+20,478
| +70% | +$361K | ﹤0.01% | 1560 |
|
|
2015
Q1 | $921K | Buy |
29,400
+13,100
| +80% | +$410K | ﹤0.01% | 1452 |
|
|
2014
Q4 | $476K | Buy |
+16,300
| New | +$476K | ﹤0.01% | 1988 |
|